A marine anthraquinone SZ-685C overrides adriamycin-resistance in breast cancer cells through suppressing akt signaling

Marine Drugs

Volumn 10, Issue 4, 2012, Pages 694-711

  Zhu, Xun ^a,b   He, Zhenjian ^a,b   Wu, Jueheng ^a,b   Yuan, Jie ^a,b   Wen, Weitao ^a,b   Hu, Yiwen ^a,b   Jiang, Yi ^a,c   Lin, Cuiji ^a,b   Zhang, Qianhui ^a   Lin, Min ^a   Zhang, Henan ^a   Yang, Wan ^a   Chen, Hong ^a   Zhong, Lili ^a   She, Zhigang ^a   Chen, Shengping ^a   Lin, Yongcheng ^a   Li, Mengfeng ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c The First People Hospital of Zigong   (China)

Author keywords

Akt; Breast cancer; Chemoresistance; SZ 685C

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 8; CASPASE 9; DOXORUBICIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN KINASE B; SZ 685C; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CANCER RESISTANCE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TREATMENT RESPONSE;

EID: 84860615475     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md10040694     Document Type: Article

References (27)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA Cancer J. Clin. 2010, 60, 277-300.
2. Gottesman, M.M. Mechanisms of cancer drug resistance. Annu. Rev. Med. 2002, 53, 615-627. (Pubitemid 34177898)
3. Molinski, T.F.; Dalisay, D.S.; Lievens, S.L.; Saludes, J.P. Drug development from marine natural products. Nat. Rev. Drug Discov. 2009, 8, 69-85.
4. Szakacs, G.; Paterson, J.K.; Ludwig, J.A.; Booth-Genthe, C.; Gottesman, M.M. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov. 2006, 5, 219-234. (Pubitemid 43336035)
5. Pritchard, K.I.; Shepherd, L.E.; O'Malley, F.P.; Andrulis, I.L.; Tu, D.; Bramwell, V.H.; Levine, M.N. HER2 and responsiveness of breast cancer to adjuvant chemotherapy. N. Engl. J. Med. 2006, 354, 2103-2111. (Pubitemid 43736610)
6. Clark, A.S.; West, K.; Streicher, S.; Dennis, P.A. Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cells. Mol. Cancer Ther. 2002, 1, 707-717.
7. Knuefermann, C.; Lu, Y.; Liu, B.; Jin, W.; Liang, K.; Wu, L.; Schmidt, M.; Mills, G.B.; Mendelsohn, J.; Fan, Z. HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells. Oncogene 2003, 22, 3205-3212. (Pubitemid 36712932)
8. Zhang, W.; Ding, W.; Chen, Y.; Feng, M.; Ouyang, Y.; Yu, Y.; He, Z. Up-regulation of breast cancer resistance protein plays a role in HER2-mediated chemoresistance through PI3K/Akt and nuclear factor-kappa B signaling pathways in MCF7 breast cancer cells. Acta Biochim. Biophys. Sin. (Shanghai) 2011, 43, 647-653.
9. Katso, R.; Okkenhaug, K.; Ahmadi, K.; White, S.; Timms, J.; Waterfield, M.D. Cellular function of phosphoinositide 3-kinases: Implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 2001, 17, 615-675. (Pubitemid 33096187)
10. Samuels, Y.; Wang, Z.; Bardelli, A.; Silliman, N.; Ptak, J.; Szabo, S.; Yan, H.; Gazdar, A.; Powell, S.M.; Riggins, G.J.; et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 2004, 304, doi:10.1126/science.1096502.
11. Yuan, T.L.; Cantley, L.C. PI3K pathway alterations in cancer: Variations on a theme. Oncogene 2008, 27, 5497-5510.
12. Knight, Z.A.; Shokat, K.M. Chemically targeting the PI3K family. Biochem. Soc. Trans. 2007, 35, 245-249. (Pubitemid 46596480)
13. Conte, P.F.; Gennari, A. Anthracyclines-paclitaxel combinations in the treatment of breast cancer. Ann. Oncol. 1997, 8, 939-943. (Pubitemid 27475722)
14. Hortobagyi, G.N. Anthracyclines in the treatment of cancer. An overview. Drugs 1997, 54, 1-7. (Pubitemid 27487789)
15. Xie, G.; Zhu, X.; Li, Q.; Gu, M.; He, Z.; Wu, J.; Li, J.; Lin, Y.; Li, M.; She, Z.; Yuan, J. SZ-685C, a marine anthraquinone, is a potent inducer of apoptosis with anticancer activity by suppression of the Akt/FOXO pathway. Br. J. Pharmacol. 2010, 159, 689-697.
16. Evan, G.I.; Vousden, K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 2001, 411, 342-348. (Pubitemid 32467043)
17. Datta, S.R.; Dudek, H.; Tao, X.; Masters, S.; Fu, H.; Gotoh, Y.; Greenberg, M.E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997, 91, 231-241. (Pubitemid 27456390)
18. Gianni, L.; Herman, E.H.; Lipshultz, S.E.; Minotti, G.; Sarvazyan, N.; Sawyer, D.B. Anthracycline cardiotoxicity: From bench to bedside. J. Clin. Oncol. 2008, 26, 3777-3784.
19. Schimmel, K.J.; Richel, D.J.; van den Brink, R.B.; Guchelaar, H.J. Cardiotoxicity of cytotoxic drugs. Cancer Treat. Rev. 2004, 30, 181-191.
20. Hofland, K.F.; Thougaard, A.V.; Sehested, M.; Jensen, P.B. Dexrazoxane protects against myelosuppression from the DNA cleavage-enhancing drugs etoposide and daunorubicin but not doxorubicin. Clin. Cancer Res. 2005, 11, 3915-3924. (Pubitemid 40685613)
21. Chien, A.J.; Moasser, M.M. Cellular mechanisms of resistance to anthracyclines and taxanes in cancer: Intrinsic and acquired. Semin Oncol. 2008, 35, S1-S14; quiz S39.
22. Batist, G.; Tulpule, A.; Sinha, B.K.; Katki, A.G.; Myers, C.E.; Cowan, K.H. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem. 1986, 261, 15544-15549.
23. Ishida, H.; Okabe, M.; Gomi, K.; Horiuchi, R.; Mikami, K.; Naito, M.; Tsuruo, T. Modulation of adriamycin resistance in human breast carcinoma MCF-7 cells in vitro and in vivo by medroxyprogesterone acetate. Jpn. J. Cancer Res. 1994, 85, 542-549. (Pubitemid 24164644)
24. Vickers, P.J.; Dickson, R.B.; Shoemaker, R.; Cowan, K.H. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol. Endocrinol. 1988, 2, 886-892.
25. Datta, S.R.; Brunet, A.; Greenberg, M.E. Cellular survival: A play in three Akts. Genes Dev. 1999, 13, 2905-2927.
26. Vanhaesebroeck, B.; Leevers, S.J.; Panayotou, G.; Waterfield, M.D. Phosphoinositide 3-kinases: A conserved family of signal transducers. Trends Biochem. Sci. 1997, 22, 267-272. (Pubitemid 27310948)
27. WinMdi, version 2.8; windows multiple document interface for flow cytometry, Scripps Research Institute: La Jolla, CA, USA, 2000.